'Lv function' presentation slideshows

????????????????

????????????????. ????????????? ???. Valvular heart disease. MITRAL STENOSIS AORTIC STENOSIS MITRAL REGURGITATION - Acute and Chronic AORTIC REGURGITATION - Acute and Chronic TRICUSPID REGURGITATION TRICUSPID STENOSIS PULMONARY STENOSIS PULMONARY REGURGITATION MIXED LESIONS. ???????.

1.28k views • 83 slides

Valvular Heart Disease

Valvular Heart Disease. ADRIEL E. GUERRERO, MD, FPCP, FPCC Training Officer Section of Cardiology, Dept of Medicine The Medical City. Mitral Stenosis. Diagnostic Features of MS @. 2/3 are females; Pure MS are generally rheumatic History: Exertional Dyspnea, PND, Orthopnea and Hemoptysis

1.7k views • 78 slides

Timing and indications of surgery in stenotic and regurgitant valvular lesions

Timing and indications of surgery in stenotic and regurgitant valvular lesions. Dr.Deepak Raju. Aortic stenosis. Pathophysiology Assessment of severity Natural history Management strategy Role of exercise test,EBCT Recommendations. Concept of afterload mismatch.

878 views • 74 slides

893 views • 74 slides

Updated Peri-operative Guidelines AND POISE Trial

651 views • 51 slides

Valvular Heart Disease

Valvular Heart Disease. J.B. Handler, M.D. Physician Assistant Program University of New England. VHD- valvular heart disease RF- rheumatic fever MR- mitral regurgitation AR- aortic regurgitation HF- congestive heart failure MS- mitral stenosis LAP- left atrial pressure

946 views • 50 slides

Assessment of LV Systolic Function

Assessment of LV Systolic Function. Dr Nithin P G. Overview. Normal LV contraction Global & regional indices of LV systolic Function Angiographic assessments Echocardiography MRI Computed Tomography Nuclear Imaging Take home message. Introduction. Mechanical pump

2.62k views • 50 slides

Gerald S. Werner, MD, FESC, FACC Klinikum Darmstadt, Germany

722 views • 47 slides

Minglong Chen, MD Division of Cardiology

Does asymptomatic patients with very frequent ventricular ectopy need prophylactic catheter ablation to prevent the development of cardiomyopathy. Minglong Chen, MD Division of Cardiology The First Affiliated Hospital of Nanjing Medical University.

541 views • 42 slides

Congestive Heart Failure

981 views • 40 slides

1.26k views • 39 slides

Optimal Management of the Post Myocardial Infarction Patient

Optimal Management of the Post Myocardial Infarction Patient. Prognosis Post MI. Mortality in the first year post MI averages 10% Subsequently mortality 5% per year 85% of deaths due to CAD 50% of these sudden 50% within first 3 months 33% within the first three weeks. b -Block.

742 views • 30 slides

Echo LV function Assessment

Echo LV function Assessment. Alfred Mureko UCT 23/03/12. LV function. 1.Systolic function 2.Diastolic function Multiple parameters. LV systolic function. Major prognostic factor in cardiac disease Systematic study through M-mode,2D and doppler flow Investigation

639 views • 26 slides

Role of Nuclear Tests in Secondary Prevention

Imaging, Management & Clinical Reserch 1 st International Symposium on Prevention of Cardiovascular Diseases June Krakow Poland. Role of Nuclear Tests in Secondary Prevention. Dr med. Magdalena Kostkiewicz Dept. of Nuclear Medicine The John Paul II Hospital Krakow Poland. Ischemic cascade.

360 views • 22 slides

Peripartum Cardiomyopathy

Peripartum Cardiomyopathy. Niloufar Samiei, MD, FACC Associate Professor of Cardiology Rajie Cardiovascular Medical and Research Center President of Iranian Society of Echocardiography. Definition

373 views • 21 slides

Mechanical Circulatory Support For Cardiogenic Shock Post AMI Asghar Khaghani Royal Brompton and Harefield NHS Trust

Mechanical Circulatory Support For Cardiogenic Shock Post AMI Asghar Khaghani Royal Brompton and Harefield NHS Trust. Mechanical Circulatory Support Cardiogenic Shock Post AMI. Difficulties:. Delayed Referral Cardiac Arrest/ Unknown neurological state Ventilated

733 views • 17 slides

Takotsubo Cardiomyopathy

Takotsubo Cardiomyopathy. Jenny Morrison ? Morning Report 4/28/2008. Takotsubo Cardiomyopathy. Cardiomyopathy characterized by transient apical and midventricular LV dysfunction in the absence of significant coronary artery disease that is triggered by emotional or physical stress.

287 views • 15 slides

Call for CASES

Call for CASES. Percutenous Controlled Reperfusion For STEMI. P iotr P. Buszman. Silesian Medical School, Katowice, Poland. Introduction. Distal emblization and reperfusion injury are a major limitations of primary percutaneous intervention in patients with STEMI. Reperfusion injury.

247 views • 10 slides

Call for CASES

Call for CASES. Percutenous Controlled Reperfusion For STEMI. P iotr P. Buszman. Silesian Medical School, Katowice, Poland. Introduction. Distal emblization and reperfusion injury are a major limitations of primary percutaneous intervention in patients with STEMI. Reperfusion injury.

106 views • 10 slides

Evolution of Myocardial Blush after MI

Evolution of Myocardial Blush after MI. 2.8%. Mean of 7.5 months. Hoffman et al, AJC 2003; 92: 1015-19. Associaiton of Myocardial Blush with LV Function at 4 Weeks. Lepper et al AJC 2001; 88:1358-1363. Evolution of Myocardial Blush after MI. 2.8%. Mean follow-up 7.5 months.

189 views • 5 slides